ALTSCHULLER Susan

Chief Financial Officer at Cerevel Therapeutics Holdings, Inc.; Officer at ImmunoGen, Inc.

Sold, on record
$572k
Dollars the filings state
Form 4 sales
1
Latest Dec 20, 2023
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice ImmunoGen, Inc.Notice
    May 5, 2023 2023

    Filed to sell 475,696 shares ($6.3M)

    ALTSCHULLER Susan, Officer

    No 10b5-1 planFirst sale on recordFiling

  2. Dec 20, 2023 +229 days

    Sold 13,808 shares at $41.42 ($572k)

    ALTSCHULLER Susan, Chief Financial Officer

    No 10b5-1 planSold 44.9% of holdings ($1.3M position)16,913 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by ALTSCHULLER Susan
Source
Dec 20, 2023Dec 21, 2023Cerevel Therapeutics Holdings, Inc.Chief Financial OfficerForm 4 sale13,808$572k44.9%UnusualSEC
May 5, 2023May 5, 2023ImmunoGen, Inc.OfficerForm 144 notice475,696$6.3MNoticeSEC